Boehringer Ingelheim Pharma GmbH & Co. KG secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tiotropium olodaterol, ATC R03AL06 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Boehringer Ingelheim Pharma GmbH & Co. KG has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement i... और पढ़ें

Heumann Pharma GmbH & Co. Generika KG secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient colchicine, ATC M04AC01 for the period 01082025 - 31072027 (plus extension option 1x12 months)

Germany, June 1 -- Germany based Heumann Pharma GmbH & Co. Generika KG has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in acco... और पढ़ें

Orifarm GmbH secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Fondaparinux, ATC B01AX05 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Orifarm GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Pa... और पढ़ें

Advanz Pharma Germany GmbH secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient lanreotide, ATC H01CB03 for the period 01072025 - 30062026 (plus extension option 1x 12 months)

Germany, June 1 -- Germany based Advanz Pharma Germany GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Sec... और पढ़ें

Vifor Pharma Deutschland secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient iron (parenteral preparations), ATC B03AC01 f d Z 011125-311027 (plus extension option 1x12 months)

Germany, June 1 -- Germany based Vifor Pharma Deutschland has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Secti... और पढ़ें

ratiopharm GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient diclofenac (exclusively GEL 25 g), ATC D11AX18 for the period 01042025 - 31032027

Germany, June 1 -- Germany based ratiopharm GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a... और पढ़ें

Gedeon Richter Pharma GmbH secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Ganirelix, ATC H01CC01 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Gedeon Richter Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Sec... और पढ़ें

Bodensee Pharma GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient bexarotene, ATC L01XF03 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Bodensee Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section... और पढ़ें

Viatris Healthcare GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient formoterol beclometasone (exclusively Dafo DOS), ATC R03AK08 for the period 01012026 - 31032026

Germany, June 1 -- Germany based Viatris Healthcare GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Sect... और पढ़ें

acis Arzneimittel GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient hydrocortisone excl Dafo TAB ATC H02AB09 fdZ 011025-300927 plus extension option 1x12 months

Germany, June 1 -- Germany based acis Arzneimittel GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Secti... और पढ़ें

• ««
• «
• 19710
• 19711
• 19712
• 19713
• 19714
• 19715
• 19716
• 19717
• 19718
• 19719
• »
• »»